Shanghai Pharmaceuticals (601607.SH): Nicardipine tablets pass consistency evaluation.

Zhixin Finance News APP, Shanghai Pharmaceuticals (601607.SH) announced that its subsidiary Shandong Xinyi Pharmaceutical Co., Ltd. ("Shandong Xinyi") received the "Drug Supplementary Application Approval Notice" issued by the National Medical Products Administration for its Nicardipine tablets. This drug has passed the evaluation of generic drug quality and efficacy consistency. Nicardipine tablets are used to treat angina.